Evidence map›Paper›PMID 21094528›Full record

ArticleMolecular immunology2011

Determinants of the endoplasmic reticulum (ER) lumenal-domain of the adenovirus serotype 2 E3-19K protein for association with and ER-retention of major histocompatibility complex class I molecules.

Jie Fu, Marlene Bouvier

Abstract read
In one paragraph

Article in Molecular immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jie FuDepartment of Microbiology and Immunology, University of Illinois at Chicago, College of Medicine, 835 S Wolcott, Chicago, IL 60612, United States.
Marlene Bouvier
University of Illinois Chicago · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR029879 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MAZZONE, THEODORE · 2009 to 2011
$11.0M
IN VITRO FOLDING AND ASSEMBLY OF CLASS I MHC MOLECULESR01AI045070 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BOUVIER, MARLENE · 2000 to 2011
$2.5M
In vitro folding and assembly of class I MHC moleculesR56AI045070 · NIAID · UNIVERSITY OF CONNECTICUT STORRS · PI BOUVIER, MARLENE · 2006 to 2006
$325k
NCRR NIH HHS UL1 RR029879NCRR NIH HHS UL1RR029879NIAID NIH HHS AI045070NIAID NIH HHS R01 AI045070NIAID NIH HHS R56 AI045070
6 · The paper itself

Abstract

The E3-19K immunomodulatory protein from adenoviruses (Ads) inhibits antigen presentation by major histocompatibility complex (MHC) class I molecules. As a result, the ability of Ad-specific cytotoxic T lymphocytes (CTLs) to lyse infected cells is suppressed. The ER-lumenal domain of E3-19K is subdivided into a variable (residues 1 to ∼78/81) and conserved (residues ∼79/82 to 98) region followed by a linker (residues 99-107). Using molecular and cellular approaches, we characterized in detail the properties of the ER-lumenal domain of E3-19K that enable it to target MHC class I molecules. Proteolysis of recombinant serotype 2 E3-19K (residues 1-100) (with six His residues) generated a large N-terminal (residues 1-88) and a small C-terminal fragment (residues 94-100) in solution. Neither of these fragments associates with HLA-A*1101 as shown by a native gel band-shift assay. In contrast, the N-terminal 1-93 residues of Ad2 E3-19K exhibited the same binding affinity to HLA-A*1101 as E3-19K. Using a site-directed mutational analysis and flow cytometry, we show that Tyr(93), but not Tyr(88), critically modulates the cell-surface expression of MHC class I molecules. Taken together, these results indicate that the sequence comprising residues 89-93 (M(89)SKQY(93)), and in particular Tyr(93), in the conserved region of E3-19K is critical for its immunomodulatory function. Residues 89-93 likely form a linker or loop in E3-19K. Overall, our data provide novel insights into the structure of E3-19K and identify key determinants for association with and ER-retention of its cellular target protein. This knowledge is important for our understanding of the molecular basis of Ad pathogenesis.

Indexed as

Adenovirus E3 ProteinsAmino AcidsAmino Acid SequenceChymotrypsinConserved SequenceEndoplasmic ReticulumHistocompatibility Antigens Class IHLA-A11 AntigenHLA-A AntigensHumansImmunomodulationMolecular Sequence DataMutagenesis, Site-DirectedPeptide FragmentsProtein BindingProtein Processing, Post-TranslationalAdenovirus E3 ProteinsAmino AcidsChymotrypsinHistocompatibility Antigens Class IHLA-A*11:01 antigenHLA-A11 AntigenHLA-A AntigensPeptide FragmentsSolutionsTyrosine

Identifiers

PMID21094528
PMCPMC3032990
OpenAlexW2050810854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.